These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19364449)

  • 1. Spasticity.
    Brashear A; Lambeth K
    Curr Treat Options Neurol; 2009 May; 11(3):153-61. PubMed ID: 19364449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic treatment of spasticity in children.
    Tilton A; Vargus-Adams J; Delgado MR
    Semin Pediatr Neurol; 2010 Dec; 17(4):261-7. PubMed ID: 21183133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the cognitive benefits of intrathecal baclofen pump implantation in people with intractable multiple sclerosis related spasticity.
    Farrell R; Summers M; Doogan C; Mulhert N; Keenan E; Buchanan K; Lee H; Padilla H; Stevenson VL
    Mult Scler Relat Disord; 2021 May; 50():102831. PubMed ID: 33618123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: a case report.
    Santamato A; Panza F; Ranieri M; Amoruso MT; Amoruso L; Frisardi V; Solfrizzi V; Fiore P
    J Rehabil Med; 2010 Oct; 42(9):891-4. PubMed ID: 20878052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin treatment of adult spasticity.
    Sheean G
    Expert Rev Neurother; 2003 Nov; 3(6):773-85. PubMed ID: 19810880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of spasticity in children with cerebral palsy].
    Matthews DJ; Balaban B
    Acta Orthop Traumatol Turc; 2009; 43(2):81-6. PubMed ID: 19448346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability.
    Charles PD; Gill CE; Taylor HM; Putman MS; Blair CR; Roberts AG; Ayers GD; Konrad PE
    Mov Disord; 2010 Mar; 25(4):466-73. PubMed ID: 20131401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury.
    Yoon YK; Lee KC; Cho HE; Chae M; Chang JW; Chang WS; Cho SR
    Medicine (Baltimore); 2017 Aug; 96(34):e7472. PubMed ID: 28834868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of spasticity in children with cerebral palsy.
    Chung CY; Chen CL; Wong AM
    J Formos Med Assoc; 2011 Apr; 110(4):215-22. PubMed ID: 21540003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations in the treatment of spasticity with intrathecal baclofen.
    Mullarkey T
    Am J Health Syst Pharm; 2009 Sep; 66(17 Suppl 5):S14-22. PubMed ID: 19710446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal baclofen for spasticity management: a comparative analysis of spasticity of spinal vs cortical origin.
    Saval A; Chiodo AE
    J Spinal Cord Med; 2010; 33(1):16-21. PubMed ID: 20397440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal baclofen for severe spasticity secondary to spinal cord injury.
    Lewis KS; Mueller WM
    Ann Pharmacother; 1993 Jun; 27(6):767-74. PubMed ID: 8329801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spasticity after stroke. Epidemiology and optimal treatment.
    O'Brien CF; Seeberger LC; Smith DB
    Drugs Aging; 1996 Nov; 9(5):332-40. PubMed ID: 8922560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A benefit-risk assessment of baclofen in severe spinal spasticity.
    Dario A; Tomei G
    Drug Saf; 2004; 27(11):799-818. PubMed ID: 15350152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spasticity: a rehabilitation challenge in the elderly.
    Barnes MP
    Gerontology; 2001; 47(6):295-9. PubMed ID: 11721141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal Baclofen therapy in Germany: Proceedings of the IAB-Interdisciplinary Working Group for Movement Disorders Consensus Meeting.
    Dressler D; Berweck S; Chatzikalfas A; Ebke M; Frank B; Hesse S; Huber M; Krauss JK; Mücke KH; Nolte A; Oelmann HD; Schönle PW; Schmutzler M; Pickenbrock H; Van der Ven C; Veelken N; Vogel M; Vogt T; Saberi FA
    J Neural Transm (Vienna); 2015 Nov; 122(11):1573-9. PubMed ID: 26179478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
    Sheean G
    Drug Saf; 2006; 29(1):31-48. PubMed ID: 16454533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacological management of post-stroke muscle spasticity.
    Bakheit AM
    Drugs Aging; 2012 Dec; 29(12):941-7. PubMed ID: 23138834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal Baclofen Infusion for the Treatment of Movement Disorders.
    Lake W; Shah H
    Neurosurg Clin N Am; 2019 Apr; 30(2):203-209. PubMed ID: 30898271
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.